Position in NMRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,245,628
+$102,205 QoQ
Shares Held
638,784
0.0% QoQ
Ownership
0.345%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NMRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AlphaCore Capital LLC holds $9,447,397 across 17 Biotechnology names. NMRA ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
41,765 | $2,699,271 | |
| 2 | IDYA |
IDEAYA Biosciences, Inc.
|
57,406 | $1,912,767 | |
| 3 | NMRA |
Neumora Therapeutics, Inc.
This page
|
638,784 | $1,245,628 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,626 | $1,172,614 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
856 | $661,379 | |
| 6 | EXEL |
Exelixis, Inc.
|
8,655 | $371,212 | |
| 7 | TECH |
BIO-TECHNE Corp
|
5,076 | $265,271 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
4,173 | $235,732 |
All Filings in NMRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,245,628 | 638,784 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,143,423 | 638,784 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,162,586 | 638,784 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $247,583 | 337,767 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||